Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. ISUDRINE (oxyde de magnésium/ phosphate d'aluminium)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ISUDRINE (oxyde de magnésium/ phosphate d'aluminium)

Medicine - Posted on Jun 08 2012 - Updated on Jun 12 2019
Active substance (DCI)
  • oxyde de magnésium
  • phosphate d'aluminium
history (4)
  • 5/23/12

    ISUDRINE (oxyde de magnésium/ phosphate d'aluminium)

    ISUDRINE (oxyde de magnésium/ phosphate d'aluminium)
    icône flèche
  • 2/15/12

    ISUDRINE (oxyde de magnésium/ phosphate d'aluminium)

    ISUDRINE (oxyde de magnésium/ phosphate d'aluminium)
    icône flèche
  • 1/23/08

    ISUDRINE (oxyde de magnésium/ phosphate d'aluminium)

    ISUDRINE (oxyde de magnésium/ phosphate d'aluminium)
    icône flèche
  • 9/18/02

    ISUDRINE, suspension buvable en sachets de 20 g (boîtes de 12)

    ISUDRINE, suspension buvable en sachets de 20 g (boîtes de 12)
    icône flèche
Technical information
ATC code
  • A02AD01
Manufacturer
BOEHRINGER INGELHEIM FRANCE
Presentation

ISUDRINE 20 g, suspension buvable en sachet Boîte de 12 - CIP : 335 719-7

All our publications
    Drug therapy Esophageal and gastrointestinal diseases Pain - Inflammation

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
JrtFcNVyFGFNVWxC